The most common Ozempic side effects are gastrointestinal: nausea, diarrhea, vomiting, and constipation. In clinical trials, roughly 1 in 5 people on the standard 1 mg dose experienced nausea, and about 1 in 7 had vomiting. These effects are usually worst during the first few weeks and tend to fade as your body adjusts. There are also rarer but more serious risks worth knowing about.
Digestive Side Effects Are the Most Common
Ozempic works by mimicking a gut hormone that slows stomach emptying and signals fullness to the brain. That mechanism is what drives weight loss and blood sugar control, but it’s also why digestive symptoms are so frequent. In a large cardiovascular outcomes trial, side effect rates at the 1 mg dose compared to placebo looked like this:
- Nausea: 21.7% vs. 7.7% on placebo
- Diarrhea: 17.7% vs. 10.8%
- Vomiting: 14.5% vs. 4.7%
- Constipation: 9.5% vs. 4.2%
The lower 0.5 mg dose had slightly lower rates across the board, with nausea at 17.3% and vomiting at 10.2%. These numbers mean digestive upset is genuinely common, not a rare reaction, but most people find it manageable.
When Side Effects Start and How Long They Last
Digestive side effects typically peak during the first four weeks of treatment and after each dose increase. Ozempic is started at a low dose and gradually increased to give your body time to adjust, but each step up can temporarily bring back nausea or other symptoms.
For most people, nausea is mild to moderate and fades after the dose escalation phase, usually within the first few weeks at each new dose level. Some people never experience side effects at all. If symptoms persist beyond the adjustment period or become severe, that’s worth flagging to your prescriber, as it may mean the dose is increasing too quickly.
How to Reduce Nausea
Simple changes to how and what you eat can make a significant difference. Because Ozempic slows stomach emptying, your stomach holds food longer than it used to. Eating large or rich meals on top of that can make nausea worse.
The most effective strategies are straightforward: eat smaller, more frequent meals instead of three large ones. Eat slowly and stop as soon as you feel satisfied, because you’ll hit fullness faster than you expect. Stay upright for at least 30 minutes after eating. Avoid greasy, fried, or heavily spiced foods, and skip very sugary desserts.
Bland foods like plain crackers, toast, and white rice tend to sit well. Clear broths help with hydration. Ginger and mint can calm an upset stomach. Cold, clear fluids work better than warm ones for many people. If nausea is severe, try sipping drinks 30 to 60 minutes before or after meals rather than during them. A short walk after eating can also help with digestion.
Gallbladder Problems and Rapid Weight Loss
Losing weight quickly, more than about 1.5 kg (3.3 pounds) per week, or losing more than 25% of your body weight increases the risk of developing gallstones. This isn’t unique to Ozempic, but it’s relevant because the drug can cause significant weight loss. On top of that, Ozempic slows the movement of bile through the gallbladder, which can lead to a buildup of sludge and stones that block the bile duct.
Watch for discomfort or a feeling of fullness in the upper right part of your abdomen, which is where the gallbladder sits. Persistent nausea that doesn’t let up, pale stools, and loss of appetite can also be warning signs. If you’re losing weight very rapidly, an ultrasound of the gallbladder can screen for problems before they become emergencies.
Pancreatitis Risk
Acute pancreatitis, a painful inflammation of the pancreas, has been reported with Ozempic, though the overall incidence remains low. In one weight loss trial, 3 out of 1,306 participants on semaglutide developed acute pancreatitis compared to none in the placebo group. A meta-analysis pooling data across multiple semaglutide trials found no statistically significant increase in pancreatitis risk compared to placebo.
Still, the possibility exists, and some cases may be linked to the gallstone issue described above, since bile duct blockages can trigger pancreatitis. The key symptoms to recognize are severe, constant abdominal pain (often radiating to the back), intractable nausea and vomiting that doesn’t resolve, and very rapid unexplained weight loss with loss of appetite.
Severe Digestive Complications
The FDA label for Ozempic includes a warning about severe gastrointestinal reactions. The drug is not recommended for people with severe gastroparesis, a condition where the stomach already empties too slowly. Since Ozempic further delays gastric emptying, it can worsen this significantly.
Postmarketing reports, meaning cases reported after the drug was on the market, have included ileus (a temporary paralysis of intestinal movement), intestinal obstruction, and severe constipation including fecal impaction. These are rare but serious. If you experience complete inability to pass gas or stool, severe bloating, or intense abdominal pain, those warrant immediate medical attention.
Thyroid Cancer Warning
Every Ozempic label carries a boxed warning, the FDA’s most prominent safety alert, about thyroid tumors. In animal studies, semaglutide caused an increased rate of medullary thyroid carcinoma (MTC) in rodents. Whether this translates to humans isn’t fully established. A recent study from Mayo Clinic suggested the link in humans may reflect detection bias rather than true causation, meaning people on these drugs get more medical monitoring and therefore more thyroid findings.
Regardless, Ozempic is contraindicated if you have a personal or family history of MTC or a condition called multiple endocrine neoplasia type 2 (MEN2). If you notice a lump or swelling in your neck, difficulty swallowing, or persistent hoarseness, those are the symptoms associated with thyroid tumors.
Eye Complications in People With Diabetes
For people who already have diabetic retinopathy, Ozempic may temporarily worsen the condition. In the SUSTAIN 6 trial, 3.0% of semaglutide users developed diabetic retinopathy complications (including bleeding in the eye and, in some cases, vision loss requiring treatment) compared to 1.8% on placebo. The risk was most pronounced in people who already had retinopathy at the start of the trial: 8.2% vs. 5.2%.
This is likely related to how quickly blood sugar drops. Rapid improvements in blood sugar control are known to temporarily worsen retinopathy across many diabetes treatments, not just Ozempic. If you have existing diabetic eye disease, more frequent eye exams during the early months of treatment are a reasonable precaution.
Injection Site Reactions
Since Ozempic is a once-weekly injection, some people experience minor reactions at the injection site: slight bleeding, redness, or mild irritation. These are generally minor and short-lived. Pressing gently with a gauze pad or cotton ball after injecting (without rubbing) can help. If irritation at the site persists or worsens, rotating injection locations between the abdomen, thigh, and upper arm can help.